Search Results - Esther Lutgens

Esther Lutgens

Esther Lutgens is a Dutch physician and molecular biologist who is Professor of Vascular Immunopathology at Amsterdam University Medical Centre. She studies the modulation of co-stimulatory pathways and the immune system. Provided by Wikipedia
Refine Results
  1. 1
    Chronic myocardial infarction in the mouse: cardiac structural and functional change

    Chronic myocardial infarction in the mouse: cardiac structural and functional change by Esther Lutgens

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease

    Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease by Esther Lutgens, Tom Seijkens

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Exploring immune checkpoints as potential therapeutic targets in atherosclerosis

    Exploring immune checkpoints as potential therapeutic targets in atherosclerosis by Pascal Kusters, Esther Lutgens, Tom Seijkens

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications

    CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications by Tom Seijkens, Pascal Kusters, David Engel, Esther Lutgens

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection

    CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection by Steffen Daub, Esther Lutgens, Thomas Münzel, Andreas Daiber

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway

    Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway by Eugene Tkachenko, Esther Lutgens, Radu V. Stan, Michael Simons

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Inflammation and immune system interactions in atherosclerosis

    Inflammation and immune system interactions in atherosclerosis by Bart Legein, Lieve Temmerman, Erik A.L. Biessen, Esther Lutgens

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Immune Cell Crosstalk in Obesity: A Key Role for Costimulation?

    Immune Cell Crosstalk in Obesity: A Key Role for Costimulation? by Tom Seijkens, Pascal Kusters, Antonios Chatzigeorgiou, Triantafyllos Chavakis, Esther Lutgens

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease

    The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease by Laura A. Bosmans, Lena Bosch, Pascal Kusters, Esther Lutgens, Tom Seijkens

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Effects of fatty acids on T cell function: role in atherosclerosis

    Effects of fatty acids on T cell function: role in atherosclerosis by Nathalie A. Reilly, Esther Lutgens, Johan Kuiper, Bastiaan T. Heijmans, J. Wouter Jukema

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    The atherogenic effect of excess methionine intake

    The atherogenic effect of excess methionine intake by Aron M. Troen, Esther Lutgens, Donald E. Smith, Irwin H. Rosenberg, Jacob Selhub

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth

    Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaq... by Aernout Luttun, Esther Lutgens, Ann Manderveld, K Maris, D Collen, Peter Carmeliet, Lieve Moons

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    CD40 in coronary artery disease: a matter of macrophages?

    CD40 in coronary artery disease: a matter of macrophages? by Matthijs Jansen, Maurits R. Hollander, Niels van Royen, Anton J.G. Horrevoets, Esther Lutgens

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential

    Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential by Charlotte Spitz, Holger Winkels, Christina Bürger, Christian Weber, Esther Lutgens, Göran K. Hansson, Norbert Gerdes

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem

    Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem by Kikkie Poels, Suzanne I.M. Neppelenbroek, Marie José Kersten, M. Louisa Antoni, Esther Lutgens, Tom Seijkens

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Absence of p55 TNF Receptor Reduces Atherosclerosis, but Has No Major Effect on Angiotensin II Induced Aneurysms in LDL Receptor Deficient Mice

    Absence of p55 TNF Receptor Reduces Atherosclerosis, but Has No Major Effect on Angiotensin II Induced Aneurysms in LDL Receptor Deficient Mice by Sofia Xanthoulea, Melanie Thelen, Chantal C. H. Pöttgens, Marion J. Gijbels, Esther Lutgens, Menno P.J. de Winther

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Transforming Growth Factor-β Mediates Balance Between Inflammation and Fibrosis During Plaque Progression

    Transforming Growth Factor-β Mediates Balance Between Inflammation and Fibrosis During Plaque Progression by Esther Lutgens, Marion Gijbels, Marjan Smook, Peter Heeringa, Philip J. Gotwals, Victor Koteliansky, Mat J.A.P. Daemen

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Atherosclerotic Plaque Destabilization

    Atherosclerotic Plaque Destabilization by Carlos Silvestre-Roig, Menno P.J. de Winther, Christian Weber, Mat J.A.P. Daemen, Esther Lutgens, Oliver Soehnlein

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

    Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype by Esther Lutgens, Kitty B.J.M. Cleutjens, Sylvia Heeneman, Victor Koteliansky, Linda C. Burkly, Mat J.A.P. Daemen

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

    The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis by Suzanne A. B. M. Aarts, Tom Seijkens, Koos J. F. van Dorst, Christine D. Dijkstra, Gijs Kooij, Esther Lutgens

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: